5'-Chloro-2'-methoxy-4'-methyl-3'-nitroacetophenone, 5g

2-Propanol, min 99,5%, pour synthèse, 5 l, emballage plastique.

3-Iodo-6-methylimidazo[1,2-a]pyridine, 95.0%, 5g

DL-Homocystine, 95.0%, 500g

6-Chloro-1,2,3,4-tetrahydro-1,5-naphthyridine, 98%, 250mg

N-(3-Iodopyridin-2-yl)pivalamide, 98%, 100g

1-Cyclohexyl-2,5-dimethyl-1H-pyrrole-3-carbaldehyde, 98%, 250mg

4-Aminobenzenesulfonic acid, sodium salt dihydrate, 95.0%, 500g

1,2-ETHANEDISULFONIC ACID, 95%, 500g

2H-Benzimidazol-2-one, 1,3-dihydro-5-[3-[4-(phenylmethyl)-1-piperidinyl]-1-propyn-1-yl]-, 98%, 25mg

4-(1h-1,3-Benzodiazol-1-ylmethyl)benzonitrile, 97%, 5g

Methyl 3-amino-6-bromopyrazine-2-carboxylate, 95.0%, 25g

5-(4-BROMOPHENYL)-1-METHYL-1H-PYRAZOLE, 95.0%, 1g